Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Sponsored by National Institute of Allergy and Infectious Diseases (NIAID)
About this study
The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below the limit of detection of the assay) among infants living with HIV.
Enrolling at this location
32515, Rush Univ./Cook County Hosp. Chicago CRS
Chicago, Illinois
I'm interestedThis study also enrolls at 5 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.